Digital Health Startups

Doxper provides digital health records and data management solutions for clinics and hospitals, enabling seamless patient data capture and real-world analytics for clinical operations and medical research.

1 investor

DrapCode builds production-ready healthcare applications on HIPAA/SOC 2-certified infrastructure, including signed BAAs, audit logs, and encrypted hosting. It serves healthcare teams and organizations that need secure, HIPAA-compliant apps delivered at a fixed price and guaranteed timeline.

1 investor

DrDoctor provides patient engagement, scheduling, and communication technology for the UK's NHS, helping hospitals reduce missed appointments, use clinic capacity, and shift toward a hybrid model of care. Its tools cover the patient journey from referral to recovery, including appointment management, digital correspondence, and health forms.

1 investor

Dreamwaves develops a navigation app for people with visual impairments that uses precise 3D spatial audio cues to guide users to their destination. The app is designed with accessibility features such as high-contrast mode, adjustable font sizes, and easy-to-use buttons, and was built in collaboration with blind associations.

1 investor

Dr. Katz offers an AI-powered, clinician-informed mental health care platform that assists both patients and providers by personalizing care and reducing administrative work. It is aimed at health systems and clinical teams to support scaled mental health care delivery.

1 investor

A healthcare organization founded by pioneers in diabetology and ophthalmology in India.

1 investor

Droice Labs builds Hawk, a HIPAA/GDPR-compliant AI middleware that uses LLMs to losslessly convert raw patient data such as EHR, labs, and claims into analysis-ready real-world data (RWD) for clinical trials. It serves pharmaceutical companies with data infrastructure and lineage tools for evidence generation across multiple diseases and international health IT systems.

1 investor

DrugBank develops a comprehensive drug knowledge base and API that provides curated, machine-learning ready data on drugs and drug products to pharmaceutical companies, researchers, and healthcare organizations. The company makes scientific findings and biomedical information accessible to improve medical outcomes and drug discovery.

1 investor

ViuHealth provides 24/7 access to mental health care through a team of licensed psychologists, psychiatrists, and other mental health professionals. The platform offers tools to support patients in managing their mental health conditions.

1 investor

DryLabz builds diagnostics technology aimed at making better use of healthcare data to support clinical decision-making. The company targets healthcare stakeholders including patients, clinicians, and insurers to enable faster, more personalized care.

1 investor

dubidoc is an online appointment management and calendar system for medical practices and MVZ (medical care centers), integrating with practice management systems (PVS) to reduce no-shows and optimize scheduling. It also offers a self-check-in feature that automates patient registration at reception, aimed at German healthcare providers.

1 investor

Dugri offers an app providing anonymous, structured peer-to-peer emotional support based on a resilience training model originally developed for first responders. It serves individuals and organizations—including medical teams, first responders, veterans, and employers—to promote mental wellness and resilience.

1 investor

Durin Technologies (Durin Life Sciences) develops Duritect blood tests that combine autoantibody biomarkers with machine learning to assess a patient's risk of Alzheimer's disease and Parkinson's disease. The diagnostic tests run in a CLIA-certified, CAP-accredited laboratory and target early detection, subtyping, and staging of neurodegenerative diseases.

1 investor

Dust is an app that records, analyzes, and guides human dreams using neuroscience research to influence dream content and lucidity. The company works with sleep scientists and artists to develop consumer products and clinical applications around dream engineering.

1 investor

Dx4Life develops a genetic swab test that identifies a biomarker to guide the choice of hormone treatment for patients undergoing IVF, delivering results in under an hour. The test is aimed at fertility clinics to help match each patient with the right hormone treatment before in vitro fertilization.

1 investor

DxLab develops multiplex molecular diagnostic technology (LAMP+) for rapid, low-cost point-of-care infectious disease testing, including its DxHub portable testing platform, DxTests, and ready-to-use LAMP master mixes. Founded by MIT and Harvard graduates, it serves public health applications such as Mpox and antimicrobial resistance detection.

1 investor

Dynamics VR develops VR therapy software and hardware packages for clinical settings. The company offers modular VR systems bundled with therapeutic software and training, designed for medical clinics and therapists.

1 investor

DYNTL builds tech-enabled onsite, nearsite, and virtual dental clinics for institutional partners such as universities, employers, union and Taft-Hartley funds, health systems, and dental plans. It provides turnkey dental service platforms, including build-out, staffing, and financial partnership, aimed at integrating oral care into broader population health strategies.

1 investor

DYSIS Medical develops computer-aided imaging technology integrated with colposcopes to help healthcare professionals detect cervical lesions more efficiently. The company manufactures and markets medical devices for cervical cancer screening and diagnosis.

1 investor

Eaglenos develops smart healthcare technologies, focusing on precision testing and personalized health management.

1 investor

Earflo makes an FDA-cleared, over-the-counter medical device built into a sippy cup that detects a child's swallows and delivers gentle air pulses through the nose to open the Eustachian tube and relieve ear fluid and pressure. It offers an at-home, non-surgical treatment for children experiencing ear fluid buildup, hearing loss, and recurrent ear infections.

1 investor

EarliPoint Health develops the EarliPoint System, an FDA-cleared medical device that uses eye-tracking to measure a child's visual attention and generate objective reports across language, cognition, and social engagement indices. The tool aids qualified clinicians in diagnosing and assessing Autism Spectrum Disorder in children 16 to 95 months old and is intended for clinical use only.

1 investor

Early develops a home urinalysis system that pairs a clinical-grade electrochemical reader with disposable urine tests to screen for markers of serious conditions such as urinary tract cancers, diabetes, kidney disease, and heart disease risk, plus wellness markers, delivering results to an app in under five minutes. The consumer product is aimed at at-home early disease detection and is planned to launch in Spring 2027.

1 investor

EarlyDx develops non-invasive liquid biopsy tests aimed at early cancer detection and precision medicine. The company positions its tests as accurate and affordable diagnostics.

1 investor